Augustina Isioma Ikusemoro: An Underrecognized Cause of Severe Thrombocytopenia Following Transfusion
Augustina Isioma Ikusemoro, Hematology and Transfusion Medicine Specialist at Sharjah Blood Transfusion and Research Center, shared a post on LinkedIn:
“Sudden severe thrombocytopenia after transfusion?
Think Post-Transfusion Purpura (PTP).
One of the most under-recognized yet critical delayed transfusion reactions in clinical practice is Post-Transfusion Purpura (PTP) — and missing it can delay life-saving treatment.
What is PTP?
A rare, immune-mediated complication that typically appears 5–10 days after transfusion, most often in previously pregnant or transfused patients, especially women.
What causes it?
The development of platelet alloantibodies, commonly anti-HPA-1a, which trigger destruction of both transfused platelets and the patient’s own platelets.
What happens clinically?
- Sudden severe thrombocytopenia (less than 10 × 10⁹/L)
- Petechiae, purpura, mucosal bleeding
- Risk of serious hemorrhage if untreated
Key diagnostic clues.
- Recent transfusion history
- Critically low platelet count
- Detection of anti-platelet antibodies
- Exclusion of other causes like TTP and ITP
Treatment is urgent — and effective when started early.
- IVIg (first-line therapy)
- Steroids as adjunct
- Plasma exchange in refractory cases
Avoid platelet transfusion unless life-threatening bleeding.
The most important takeaway?
PTP is treatable — but only if recognized early.
When unexplained severe thrombocytopenia appears days after transfusion, pause and consider PTP.
Early recognition saves lives.
Signature of Blood Doki.
Educate. Empower. Elevate.”
Other posts featuring Augustina Isioma Ikusemoro on Hemostasis Today.
-
May 31, 2026, 16:29José Antonio García Erce: Collaborative PBM Implementation in Transfusion Centers and Services
-
May 31, 2026, 16:22Vera Ignjatović: How Do We Rigorously Study These Drugs in Children to Understand Their True Benefits and Risks?
-
May 31, 2026, 16:21Ksenija Stach: Is This The Future of Lipid-Lowering Lherapy?
-
May 31, 2026, 15:42Antonio Greco: Balancing Bleeding and Thrombotic Risk After PCI
-
May 31, 2026, 15:41Eric Topol: Replication of Plasma p-tau217 Blood Test for Predicting Alzheimer’s Disease
-
May 31, 2026, 15:32ASH Invites Dynamic Members to Apply for 2027 Leadership and Committee Roles
-
May 31, 2026, 14:39Monique Gore-Massy: Redefining Lupus Innovation Through Patient Partnership
-
May 31, 2026, 14:31Mirjam Teboe: The Golden Rule Behind Reliable Lupus Anticoagulant Testing
-
May 31, 2026, 14:20Improving Access to Care for People Living with Haemophilia and Haemoglobinopathies – NNHF